These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3315596)

  • 21. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.
    Been M; de Bono DP; Muir AL; Boulton FE; Hillis WS; Hornung R
    Br Heart J; 1985 Mar; 53(3):253-9. PubMed ID: 3882107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings.
    Hellstern P; Doenecke P; Köhler M; Schwerdt H; Ozbek C; Miyashita C; Bette L; Wenzel E
    Drugs; 1987; 33 Suppl 3():183-5. PubMed ID: 3315589
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex.
    Kasper W; Meinertz T; Wollschläger H; Bonzel T; Wolff P; Drexler H; Hofmann T; Zeiher A; Just H
    Am J Cardiol; 1986 Sep; 58(6):418-21. PubMed ID: 3529908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    de Swart JB
    Drugs; 1987; 33 Suppl 3():279-81. PubMed ID: 3315607
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML; Quilliet L; Kulbertus H; Materne P; Letac B; Cribier A; Monassier JP; Sacrez A; Favier JP
    Drugs; 1987; 33 Suppl 3():140-5. PubMed ID: 3315581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerance data from the Belgian multicentre study of anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction.
    Bossaert LL
    Drugs; 1987; 33 Suppl 3():287-92. PubMed ID: 3315610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anistreplase: a novel thrombolytic agent for acute myocardial infarction.
    Marinac JS; North DS; Stringer KA
    DICP; 1990 Jun; 24(6):607-15. PubMed ID: 2193460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Ikram S; Lewis S; Bucknall C; Sram I; Thomas N; Vincent R; Chamberlain D
    Br Med J (Clin Res Ed); 1986 Sep; 293(6550):786-9. PubMed ID: 3094657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin.
    Croydon EA
    Drugs; 1987; 33 Suppl 3():293-6. PubMed ID: 3315611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of anistreplase from the placebo-controlled AIMS study (anistreplase Intervention Mortality Study). The AIMS Study Group.
    Fox KA
    Clin Cardiol; 1990 Mar; Suppl 5():V22-6; discussion V27-32. PubMed ID: 2182237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
    Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Bossaert LL; Demey HE; Colemont LJ; Beaucourt L; Fierens H; Dirix L; Pintens H
    Crit Care Med; 1988 Sep; 16(9):823-30. PubMed ID: 3042284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction.
    Meinertz T; Kasper W; Schumacher M; Just H
    Am J Cardiol; 1988 Sep; 62(7):347-51. PubMed ID: 3046283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Bucknall C; Darley C; Flax J; Vincent R; Chamberlain D
    Br Heart J; 1988 Jan; 59(1):9-11. PubMed ID: 2963655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion Study.
    Hoffmann JJ; Bonnier JJ; de Swart JB; Custers P; Vijgen M
    Drugs; 1987; 33 Suppl 3():242-6. PubMed ID: 3315602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The APSAC interventional mortality study (AIMS) trial: mortality data.
    Julian DG
    Clin Cardiol; 1990 Mar; Suppl 5():V20-1; discussion V27-32. PubMed ID: 2182236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of left ventricular function in a randomised study of intravenous anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Preliminary results of the European Multicentre Study (Belgian Centres).
    Taeymans Y; Materne P
    Drugs; 1987; 33 Suppl 3():216-20. PubMed ID: 3315594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ
    Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.